Form 4 for CNMD CONMED Corp
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-25 · accession 0001127602-22-007313 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-01 | 2022-02-25 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | M - OptEx | $89.46 | +8,843 | 15.5K | +133% | +$791.1K |
| DM | 2022-03-01 | 2022-02-25 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | S - Sale+OE | $149.55 | -8,843 | 12.2K | -42% | -$1.32M |
| DM | 2022-03-01 | 2022-02-25 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | M - OptEx | $0.00 | -8,843 | 24.5K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-25 | M | A | 3,755 | $97.69 | 15,922 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-25 | S | D | 1,245 | $150.00 | 12,167 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-25 | M | A | 500 | $78.76 | 12,667 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-25 | M | A | 1,245 | $97.69 | 13,412 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-25 | S | D | 3,343 | $149.41 | 12,167 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.63. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 6 | Common | Common Stock | 2022-02-25 | M | A | 3,343 | $78.76 | 15,510 | D | — | — | |
| 7 | Common | Common Stock | 2022-02-25 | S | D | 500 | $150.03 | 12,167 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.16. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 8 | Common | Common Stock | 2022-02-25 | S | D | 3,755 | $149.46 | 12,167 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.56. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 9 | Derivative | Options To Purchase Common Stock | 2022-02-25 | M | D | 3,755 | $0.00 | 20,000 | D | $97.69 · — to 2030-03-02 | 3,755 Common Stock | (F4) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 10 | Derivative | Options To Purchase Common Stock | 2022-02-25 | M | D | 1,245 | $0.00 | 23,755 | D | $97.69 · — to 2030-03-02 | 1,245 Common Stock | (F4) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 11 | Derivative | Options To Purchase Common Stock | 2022-02-25 | M | D | 3,343 | $0.00 | 21,157 | D | $78.76 · — to 2029-03-01 | 3,343 Common Stock | (F4) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 12 | Derivative | Options To Purchase Common Stock | 2022-02-25 | M | D | 500 | $0.00 | 24,500 | D | $78.76 · — to 2029-03-01 | 500 Common Stock | (F4) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |